Cell Culture Market Share to reach USD 44.33 Billion, Globally, by 2028

According to our latest study on "Cell Culture Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Product, Application, End User, and Geography," the market was valued at US$ 21,722.8 million in 2021 and is likely to reach US$ 44,330.1 million by 2028; it is expected to grow at a CAGR of 10.7% from 2022 to 2028.

The cells used to manufacture vaccines are frozen or banked, ensuring an adequate supply of cells for vaccine production. The adoption of cell culture vaccines has grown in recent years due to potential applications in developing viral vaccines, particularly for influenza.

Get Sample Brochure at https://www.theinsightpartners.com/sample/TIPRE00003472?utm_source=OpenPR&utm_medium=10051

IMPACT OF COVID-19 PANDEMIC

According to the World Health Organization (WHO), as of August 2022, there were 596,873,121 confirmed cases of COVID-19 and 6,459,684 deaths. The highest number of deaths was in the Americas, followed by Europe and Southeast Asia.

The COVID-19 pandemic has prompted vital pharmaceutical and biotechnology companies to produce several vaccines or antiviral drugs for COVID-19 management. A few vaccines have been approved or are under development and manufacturing. Cell culture is an integral part of drug development and manufacturing. Thus, the COVID-19 pandemic had a positive impact on the cell culture market.

Thermo Fisher Scientific Inc.; Merck KGaA; Danaher Corporation; Corning Incorporated; Eppendorf AG; FUJIFILM Irvine Scientific, Inc.; Lonza Group AG; Sartorius AG; Agilent Technologies, Inc.; and Getinge AB are among the key players profiled during the study of the cell culture market. Several other major companies were studied and analyzed during this research study to get a holistic view of the market and its ecosystem.

Key players involved in the cell culture market are undertaking initiatives to extend their product portfolios and strengthen their market position. For instance, in January 2022, Cytiva (Danaher Corporation) collaborated with Nucleus Biologics to develop custom culture media for cell and gene therapies. Furthermore, market players are making developments in their existing service offerings to improve their market presence. For instance, in February 2022, KromaTiD expanded its service offerings by launching cell and blood culture isolation, processing, and quality control services. Additionally, in November 2019, Thermo Fisher Scientific announced the investment of US$ 250 million in the US, India, the UK, Argentina, and China. The investment would boost its ability to manufacture cell culture media and expects to complete the work by 2021.

The increasing incidence of infectious diseases, such as common cold, diphtheria, E. coli., giardiasis, HIV/AIDS, and the growing risk of COVID 19 outbreak are anticipated to drive vaccine demand worldwide in the coming years. For instance, in India, almost everyone experiences a common cold twice a year, accounting for at least 40-50% of new cases of common cold. Additionally, as per the National Centre for Disease Control (NCDC), in 2019, 28,798 H1N1 cases and 1,218 deaths were reported. Cell culture has become a prominent part of vaccine production in the pharmaceutical industry. Cell culture technology has produced vaccines for rotavirus, polio, smallpox, hepatitis, rubella, and chickenpox.

Buy Complete Report at https://www.theinsightpartners.com/buy/TIPRE00003472?utm_source=OpenPR&utm_medium=10051

Also:
Lentiviral Vectors Market
https://www.marketwatch.com/press-release/lentiviral-vectors-market-analysis-by-regional-overview-industry-perspective-revenue-and-forecast-to-2028-2022-09-26

Cartilage Regeneration Technology Market
https://www.marketwatch.com/press-release/cartilage-regeneration-technology-market-opportunities-and-trends-analysis-to-2028-2022-09-26

Lipidomics Market
https://www.marketwatch.com/press-release/lipidomics-market-growth-factors-details-by-application-drug-discovery-biomarker-discovery-personalized-medicine-diagnosis-and-treatment-2022-09-26

Genetic Modification Therapies Market
https://www.marketwatch.com/press-release/genetic-modification-therapies-market-analysis-by-emerging-trends-leading-competitors-and-sector-opportunities-till-2028-2022-09-26

Vaccines And Vaccination Market
https://www.marketwatch.com/press-release/vaccines-and-vaccination-market-analysis-by-business-opportunities-growth-drivers-and-prominent-investment-by-2028-2022-09-26

Biological Data Visualization Market
https://www.marketwatch.com/press-release/biological-data-visualization-market-analysis-by-country-revenue-share-key-players-and-international-forecasts-by-2028-2022-09-26

Vitrification Market
https://www.marketwatch.com/press-release/vitrification-market-key-factors-industry-analysis-and-top-manufactures-by-2028-2022-09-26

Lateral Flow Assay Test Market
https://www.marketwatch.com/press-release/lateral-flow-assay-test-market-country-revenue-share-growth-scenario-and-key-factors-forecast-2022-2028-2022-09-26

Vitamin B4 Market
https://www.marketwatch.com/press-release/vitamin-b4-market-size-2022---analysis-by-grade-feed-grade-food-grade-pharma-grade-till-2028-2022-09-26

Food Coating Market
https://www.marketwatch.com/press-release/food-coating-market-size-overview-till-2028---share-forecasts-by-newly-weds-foods-pgp-international-sensoryeffects-balchem-corporation-tate-lyle-plc-2022-09-26

Advanced Glycation End Products Market
https://www.marketwatch.com/press-release/advanced-glycation-end-products-market-growth-is-booming-with-rise-in-the-cases-of-cancer-globally-by-2028-2022-09-26

Email: sales@theinsightpartners.com
Phone : +1-646-491-9876

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

This release was published on openPR.